Drawing for INNOMEDICS

USPTO serial 76150463

INNOMEDICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
FARRELL, ANNE M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INNOMEDICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adrienne L. White

ADRIENNE L WHITE BURNS, DOANE, SWECKER & MATHIS, LLPP O BOX 1404ALEXANDRIA, VA 22313-1404UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in the treatment of neurological diseases, cancer, hormonal disorders, inflammatory diseases and cardiovascular diseases; veterinary preparations for the treatment of infections in pets and for sedation of pets; sanitary preparations, namely, antibacterial handwash, antiseptics, general purpose germicide, sanitizers for hospital use; dietetic substances adapted for medical use, namely, food for medically restricted diets, food for diabetics, food for enteral feeding, food supplements, meal replacement drinks, meal replacement powders; food for babies; medical plaster, corn plasters; materials for dressings, namely, wound dressings, burn dressings, surgical dressings, adhesive bandages, surgical bandages, bandages for skin wounds, gauze; materials for stopping teeth, dental waxACTIVE
035Direct mail advertising and electronic billboard advertising for others, advertising agencies, business management, business administration, office functions and business marketing consulting services in the fields of health care, pharmaceuticals and functional food productsACTIVE
042Consultation in the fields of health care, pharmaceuticals and functional food productsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 18, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 9, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 16, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2002NPUBNOTICE OF PUBLICATION
Dec 4, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 23, 2001DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance